1.
Fuca G, Verzoni E, Mennitto A, Prisciandaro M, Ratta R, Procopio G. Real-world safety profile of abiraterone acetate in patients with castration-resistant prostate cancer and cardiovascular comorbidities: a retrospective, single center study:  . CBN [Internet]. 2017 Dec. 15 [cited 2024 Dec. 14];5(3):20-4. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/191